Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000500200 | SCV000594414 | likely benign | not specified | 2015-10-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000537148 | SCV000651645 | benign | Charcot-Marie-Tooth disease axonal type 2O | 2024-11-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001722423 | SCV000722740 | benign | not provided | 2020-12-17 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001172864 | SCV001335937 | likely benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV002341184 | SCV002635441 | benign | Inborn genetic diseases | 2019-08-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003900042 | SCV004711226 | likely benign | DYNC1H1-related disorder | 2019-06-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |